By applying our in-house developed FCVPPv2 on a CRC-affected family, we were able to prioritize two novel heterozygous germline variants, a coding variant in APCDD1 and a non-coding variant in the HDAC5 gene. Here, HDAC5 is linked to colorectal carcinoma.